JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M100638200 on February 26, 2001

J. Biol. Chem., Vol. 276, Issue 21, 18497-18506, May 25, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/21/18497    most recent
M100638200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isaacs, J. S.
Right arrow Articles by Neckers, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isaacs, J. S.
Right arrow Articles by Neckers, L. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Requirement for HDM2 Activity in the Rapid Degradation of p53 in Neuroblastoma*

Jennifer S. IsaacsDagger , Shin'ichi Saito§, and Leonard M. NeckersDagger

From Dagger  Tumor Cell Biology Section, Medicine Branch, NCI, National Institutes of Health, Rockville, Maryland 20850 and the § Laboratory of Cell Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892-1152

The wild type p53 tumor suppressor protein is rapidly degraded in normal cells by MDM2, the ubiquitin ligase that serves as the key regulator of p53 function by modulating protein stability. Cellular exposure to genotoxic stress triggers the stabilization of p53 by multiple pathways that converge upon interference with MDM2 function. In this study, we first investigated the ability of HDM2 (MDM2 human homologue) to degrade endogenous p53 in neuroblastoma (NB). Although the p53 protein in NB has been reported to be constitutively stabilized, we find that HDM2 in NB is functional and facilitates the rapid turnover of p53 in nonstressed cells via the proteasome pathway. Second, we examined the relationship between p53 and HDM2 in the adriamycin-mediated stabilization of p53 in NB. We demonstrate that while p53 stabilization depends neither upon the phosphorylation of specific N-terminal sites nor upon dissociation from HDM2, it requires inactivation of functional HDM2. In support of this notion, p53 stabilization following adriamycin resulted in an inhibition of both p53 ubiquitination and HDM2 ligase activity. Taken together, these data implicate a requirement for enzymatic inactivation of HDM2 as a novel mechanism for p53 stabilization in the DNA damage response pathway.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Tumor Cell Biology, Medicine Branch, NCI, NIH, KWC Ste. 300, 9610 Medical Center Dr., Rockville, MD 20850. Tel.: 301-402-3128 (ext. 318); Fax: 301-402-4422; E-mail: len@helix.nih.gov.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J.-H. Lee, M.-W. Jeong, W. Kim, Y. H. Choi, and K.-T. Kim
Cooperative Roles of c-Abl and Cdk5 in Regulation of p53 in Response to Oxidative Stress
J. Biol. Chem., July 11, 2008; 283(28): 19826 - 19835.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J.-H. Lee, H.-S. Kim, S.-J. Lee, and K.-T. Kim
Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death
J. Cell Sci., July 1, 2007; 120(13): 2259 - 2271.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
E. Barbieri, P. Mehta, Z. Chen, L. Zhang, A. Slack, S. Berg, and J. M. Shohet
MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death.
Mol. Cancer Ther., September 1, 2006; 5(9): 2358 - 2365.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. K. Koblish, S. Zhao, C. F. Franks, R. R. Donatelli, R. M. Tominovich, L. V. LaFrance, K. A. Leonard, J. M. Gushue, D. J. Parks, R. R. Calvo, et al.
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo
Mol. Cancer Ther., January 1, 2006; 5(1): 160 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Saville, A. Sparks, D. P. Xirodimas, J. Wardrop, L. F. Stevenson, J.-C. Bourdon, Y. L. Woods, and D. P. Lane
Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo
J. Biol. Chem., October 1, 2004; 279(40): 42169 - 42181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.'i. Saito, X.-F. Liu, K. Kamijo, R. Raziuddin, T. Tatsumoto, I. Okamoto, X. Chen, C.-C. Lee, M. V. Lorenzi, N. Ohara, et al.
Deregulation and Mislocalization of the Cytokinesis Regulator ECT2 Activate the Rho Signaling Pathways Leading to Malignant Transformation
J. Biol. Chem., February 20, 2004; 279(8): 7169 - 7179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. S. Kiat, K. M. Hui, and G. Gopalan
Aurora-A Kinase Interacting Protein (AIP), a Novel Negative Regulator of Human Aurora-A Kinase
J. Biol. Chem., November 15, 2002; 277(47): 45558 - 45565.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.'i. Saito, A. A. Goodarzi, Y. Higashimoto, Y. Noda, S. P. Lees-Miller, E. Appella, and C. W. Anderson
ATM Mediates Phosphorylation at Multiple p53 Sites, Including Ser46, in Response to Ionizing Radiation
J. Biol. Chem., April 5, 2002; 277(15): 12491 - 12494.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.